(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a ...
Q4 2024 Earnings Call Transcript January 30, 2025 Operator: Good day. And welcome to the Altria Group 2024 Fourth Quarter and ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
Plus, NBC News spoke to trans service members about their thoughts on President Trump's executive order banning trans people from enlisting and serving in the military.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.